BamSEC and AlphaSense Join Forces
Learn More

enGene Therapeutics Inc. – Material Contracts

NASDAQ: ENGN    
Share price (9/24/26): $1.92    
Market cap (9/24/26): $129 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.9(B)
from 10-Q 4 pages Form of Retention Bonus Agreement
12/34/56
EX-10.9(A)
from 10-Q 4 pages Form of Retention Bonus Agreement
12/34/56
EX-10.11
from 10-Q 11 pages enGene Holdings Inc. Amended and Restated 2023 Equity Incentive Plan Restricted Share Unit Agreement
12/34/56
EX-10.10
from 10-Q 8 pages enGene Holdings Inc. Amended and Restated 2023 Equity Incentive Plan Nonqualified Stock Option Grant Agreement
12/34/56
EX-10.8
from 10-Q 4 pages Form of Retention Bonus Agreement
12/34/56
EX-10.6
from 10-Q 10 pages June 15, 2026 (Revised as Requested on July 7, 2026) by Email Anthony Cheung Re: Transition Services Agreement & General Release Dear Anthony: This Letter of Agreement and General Release (“Agreement”) Confirms Our Mutual Agreement Regarding the Terms and Conditions of Your Separation From Employment With enGene Inc. (“Engene” or the “Company”) and Transition to a Consultant. You and the Company Agree as Follows: 1
12/34/56
EX-10.5
from 10-Q 13 pages June 15, 2026 (Revised as Requested on July 13, 2026) by Email Alexander Nichols Re: Separation Agreement & General Release Dear Alex: This Letter of Agreement and General Release (“Agreement”) Confirms Our Mutual Agreement Regarding the Terms and Conditions of Your Separation From Employment With enGene USA, Inc. (“Engene” or the “Company”). You and the Company Agree as Follows: 1
12/34/56
EX-10.4
from 10-Q 12 pages June 15, 2026 by Email Lee G. Giguere Re: Separation Agreement & General Release Dear Lee: This Letter of Agreement and General Release (“Agreement”) Confirms Our Mutual Agreement Regarding the Terms and Conditions of Your Separation From Employment With enGene USA, Inc. (“Engene” or the “Company”). You and the Company Agree as Follows: 1
12/34/56
EX-10.3
from 10-Q 12 pages June 15, 2026 by Email David Ryan Daws Re: Separation Agreement & General Release Dear Ryan: This Letter of Agreement and General Release (“Agreement”) Confirms Our Mutual Agreement Regarding the Terms and Conditions of Your Separation From Employment With enGene USA, Inc. (“Engene” or the “Company”). You and the Company Agree as Follows: 1
12/34/56
EX-10.2
from 10-Q 9 pages Employment Agreement for William Grossman
12/34/56
EX-10.1
from 10-Q 16 pages Employment Agreement for Kathleen Richton
12/34/56
EX-10.3
from 10-Q 16 pages Amended and Restated Employment Agreement for Hussein Sweiti
12/34/56
EX-10.2
from 10-Q 13 pages Second Amended & Restated Employment Agreement for Anthony Cheung
12/34/56
EX-10.20(B)
from 10-K 2 pages Amendment to Employment Agreement for Ronald H. W. Cooper
12/34/56
EX-10.32
from 10-K 16 pages Employment Agreement for Hussein Sweiti
12/34/56
EX-10.7
from 10-Q 13 pages Employment Agreement for Matthew Boyd
12/34/56
EX-10.6
from 10-Q 13 pages Employment Agreement for Jill Buck
12/34/56
EX-10.3
from 10-Q 16 pages Amended & Restated Employment Agreement for Ryan Daws
12/34/56
EX-10.2
from 10-Q 16 pages Employment Agreement for Amy Pott
12/34/56
EX-10.1
from 8-K 14 pages enGene Holdings Inc. 2025 Employee Stock Purchase Plan
12/34/56